Next Science Limited (NXS.AX)
AUD 0.12
(0.0%)
AUD 0.12
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -24.51 Million USD | -33.98% |
| 2022 | -18.29 Million USD | -46.88% |
| 2021 | -12.45 Million AUD | 28.01% |
| 2020 | -17.3 Million AUD | 16.22% |
| 2019 | -20.65 Million AUD | -12.17% |
| 2018 | -18.41 Million AUD | -28969.33% |
| 2017 | -63.33 Thousand AUD | 98.13% |
| 2016 | -3.39 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.75 Million AUD | 26.91% |
| 2023 FY | -24.51 Million USD | -33.98% |
| 2023 Q2 | -12.74 Million AUD | -40.12% |
| 2023 Q4 | -11.73 Million AUD | 7.95% |
| 2022 Q2 | -9.16 Million AUD | -30.2% |
| 2022 FY | -18.29 Million USD | -46.88% |
| 2022 Q4 | -9.09 Million AUD | 0.74% |
| 2021 FY | -12.45 Million AUD | 28.01% |
| 2021 Q2 | -5.44 Million AUD | 24.59% |
| 2021 Q4 | -7.04 Million AUD | -29.35% |
| 2020 FY | -17.3 Million AUD | 16.22% |
| 2020 Q2 | -10.19 Million AUD | 10.19% |
| 2020 Q4 | -7.21 Million AUD | 29.23% |
| 2019 Q4 | -11.35 Million AUD | -21.85% |
| 2019 FY | -20.65 Million AUD | -12.17% |
| 2019 Q2 | -9.31 Million AUD | -58.72% |
| 2018 FY | -18.41 Million AUD | -28969.33% |
| 2018 Q4 | -5.87 Million AUD | 0.0% |
| 2017 FY | -63.33 Thousand AUD | 98.13% |
| 2016 FY | -3.39 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Althea Group Holdings Limited | -32.05 Million AUD | 23.533% |
| Cann Group Limited | -51.24 Million AUD | 52.163% |
| ECS Botanics Holdings Ltd | 1.91 Million AUD | 1379.668% |
| Ecofibre Limited | -44.34 Million AUD | 44.721% |
| Elixinol Wellness Limited | -7.5 Million AUD | -226.533% |
| Hygrovest Limited | -131 Thousand AUD | -18612.113% |
| IDT Australia Limited | -5.41 Million AUD | -352.852% |
| Invion Limited | -5.62 Million AUD | -335.57% |
| Little Green Pharma Ltd | -9.2 Million AUD | -166.287% |
| Live Verdure Ltd | -12.9 Million AUD | -89.907% |
| Medical Developments International Limited | -40.99 Million AUD | 40.201% |
| Vitura Health Limited | 3.51 Million AUD | 797.899% |
| Vita Life Sciences Limited | 9.08 Million AUD | 369.966% |